AML Including AML de Novo and AML Secondary to MDS
1 clinical trials · Condition
◉ Watch AML Including AML de Novo and AML Secondary to MDS
| Record | Firm | Date |
|---|---|---|
| A Dose Exploration Study With Birabresib (MK-8628) in Participants With Selected Hematologic Malignancies (MK-8628-005) (NCT02698189) | Merck Sharp & Dohme LLC | 2016-05-19 |
Track AML Including AML de Novo and AML Secondary to MDS automatically
Every clearance here is in the API, with alerts when new ones post.